Andreas Holbro

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Diagnostic performance and interchangeability of two commercial anti-RSV-IgG and IgA ELISAs across clinically relevant populations.

Diagnostic performance and interchangeability of two commercial anti-RSV-IgG and IgA ELISAs across clinically relevant populations.

Journal: Microbiology spectrum

Published: June 26, 2026

Cellular profile of hematopoietic stem cells mobilized by exercise versus G-CSF in healthy related donors.

Cellular profile of hematopoietic stem cells mobilized by exercise versus G-CSF in healthy related donors.

Journal: European journal of applied physiology

Published: December 23, 2025

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up.

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up.

Journal: Research and practice in thrombosis and haemostasis

Published: December 05, 2025

Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia.

Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia.

Journal: British journal of haematology

Published: August 22, 2025

Genetically engineered T cell and tumour-infiltrating lymphocyte therapies.

Genetically engineered T cell and tumour-infiltrating lymphocyte therapies.

Journal: Swiss medical weekly

Published: August 14, 2025

Successful treatment with Tislelizumab and Zanubrutinib in a patient with relapsed/refractory, CD19/CD20 negative Richter's transformed CLL.

Successful treatment with Tislelizumab and Zanubrutinib in a patient with relapsed/refractory, CD19/CD20 negative Richter's transformed CLL.

Journal: Bone marrow transplantation

Published: August 06, 2025

Basic Concepts and Indications of CAR T Cells.

Basic Concepts and Indications of CAR T Cells.

Journal: Hamostaseologie

Published: February 19, 2025

The Changing Role of Allogeneic Stem Cell Transplantation in Adult B-ALL in the Era of CAR T Cell Therapy.

The Changing Role of Allogeneic Stem Cell Transplantation in Adult B-ALL in the Era of CAR T Cell Therapy.

Journal: Current oncology (Toronto, Ont.)

Published: January 31, 2025

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma.

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma.

Journal: Immuno-oncology technology

Published: January 13, 2025

High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia.

High pretreatment peripheral blood T-cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia.

Journal: British journal of haematology

Published: November 25, 2024

Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors.

Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors.

Journal: Cancer immunology research

Published: October 23, 2024

Blood donation for iron removal in individuals with HFE mutations: study of efficacy and safety and short review on hemochromatosis and blood donation.

Blood donation for iron removal in individuals with HFE mutations: study of efficacy and safety and short review on hemochromatosis and blood donation.

Journal: Frontiers in medicine

Published: December 29, 2023

Showing 1-12 of 98

Last Updated: 09/26/2026